triazoles has been researched along with Long Sleeper Syndrome in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 5 (23.81) | 2.80 |
| Authors | Studies |
|---|---|
| Allocca, G; Chu, J; Cornthwaite-Duncan, L; Daykin, H; Hoyer, D; Jacobson, LH; Keenan, RJ | 1 |
| Besuyen, R; Coates, LC; Gao, J; Gossec, L; Hendrikx, T; Leung, YY; Meuleners, L; Ogdie, A; Orbai, AM; Tasset, C; Tillett, W; Trivedi, M | 1 |
| Ando, Y; Hirose, T; Kumashiro, N; Miyagi, M; Shigiyama, F; Uchino, H; Yoshikawa, F | 1 |
| McCleery, J; Sharpley, AL | 1 |
| Sasaoka, T; Tsuneki, H; Wada, T | 1 |
| Hayakawa, T; Moriyama, S; Takeuchi, Y; Yanai, H | 1 |
| Campbell, EJ; Lawrence, AJ; Marchant, NJ | 1 |
| Benedict, J; Ehlers, CL; Sanchez-Alavez, M; Wills, DN | 1 |
| Bauer, M; Hadji, P; Hars, O; Kalder, M; Kyvernitakis, I; Ziller, V | 1 |
| Bergin, AM; Bolton, J; Bourgeois, BF; Harini, C; Kadish, NE; Kapur, K; Kothare, SV; Libenson, M; Loddenkemper, T; Olson, H; Peters, J; Poduri, A; Ramgopal, S; Rotenberg, A; Sánchez Fernández, I; Takeoka, M; Thome-Souza, S | 1 |
| Bowman, M; Bruner, D; DeMichele, A; Farrar, JT; Mao, JJ; Seluzicki, C; Xie, SX; Zee, J | 1 |
| Brownlow, JA; Harb, GC; Ross, RJ | 1 |
| Hori, S; Miki, A; Sawada, Y; Shihyakugari, A | 1 |
| Kamei, C; Kitamura, Y; Obara, Y; Shinomiya, K; Takeda, Y; Tsutsui, R | 1 |
| Mieda, M; Sakurai, T | 1 |
| Amow, B; Borian, FE; Dunner, DL; Keller, B; Klein, D; Korenstein, SG; Manber, R; Markowitz, JC; Munsaka, M; Rush, AJ; Thase, ME; Trivedi, MH | 1 |
| Albala, BJ; Erman, MK; Gillin, JC; Rapaport, M; Winokur, A | 1 |
| Hickie, I | 1 |
| Brady, KT; Charney, DS; Grothe, DR; Kaltsounis-Puckett, J; Laird, LK; Rush, AJ; Smith, SL; Wright, CW | 1 |
| Brunson, GH; Hales, RE; Hilty, DM | 1 |
| Antonelli, F; De Gregorio, M; Dionisio, A | 1 |
7 review(s) available for triazoles and Long Sleeper Syndrome
| Article | Year |
|---|---|
Pharmacotherapies for sleep disturbances in dementia.
Topics: Alzheimer Disease; Azepines; Caregiver Burden; Cognition; Humans; Indenes; Melatonin; Pyridines; Pyrimidines; Randomized Controlled Trials as Topic; Sleep; Sleep Wake Disorders; Time Factors; Trazodone; Triazoles | 2020 |
Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
Topics: Azepines; Circadian Rhythm; Humans; Life Style; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Quality of Life; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Triazoles | 2018 |
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Topics: Alcoholism; Animals; Azepines; Humans; Orexin Receptor Antagonists; Sleep Wake Disorders; Substance Withdrawal Syndrome; Triazoles | 2020 |
Treatment of Sleep Disturbances in Post-Traumatic Stress Disorder: A Review of the Literature.
Topics: Antipsychotic Agents; Cognitive Behavioral Therapy; Dreams; Eye Movement Desensitization Reprocessing; Fluvoxamine; Humans; Piperazines; Prazosin; REM Sleep Behavior Disorder; Restless Legs Syndrome; Serotonin and Noradrenaline Reuptake Inhibitors; Sleep; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Stress Disorders, Post-Traumatic; Trazodone; Triazoles | 2015 |
Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status.
Topics: Animals; Azepines; Clinical Trials, Phase III as Topic; Humans; Orexin Receptors; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Sleep Wake Disorders; Triazoles; Wakefulness | 2013 |
Overview of psychiatric disorders and the role of newer antidepressants.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder; Humans; Mental Disorders; Piperazines; Sleep Wake Disorders; Triazoles | 2002 |
Cost savings with nefazodone in treating depression.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cost Savings; Depressive Disorder; Drug Costs; Drug Therapy, Combination; Health Care Costs; Humans; Hypnotics and Sedatives; Piperazines; Sleep Wake Disorders; Triazoles | 2002 |
7 trial(s) available for triazoles and Long Sleeper Syndrome
| Article | Year |
|---|---|
Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR).
Topics: Adaptation, Psychological; Arthritis, Psoriatic; Double-Blind Method; Fatigue; Humans; Janus Kinase Inhibitors; Least-Squares Analysis; Minimal Clinically Important Difference; Pain; Physical Functional Performance; Psoriasis; Pyridines; Quality of Life; Sleep Wake Disorders; Social Behavior; Treatment Outcome; Triazoles | 2020 |
Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Anxiety; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Hot Flashes; Humans; Letrozole; Medication Adherence; Middle Aged; Musculoskeletal Pain; Nitriles; Sleep Wake Disorders; Time Factors; Triazoles; Urinary Bladder Diseases; Vaginal Diseases | 2014 |
Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial.
Topics: Aged; Anastrozole; Androstadienes; Anxiety; Aromatase Inhibitors; Arthralgia; Breast Neoplasms; Depression; Electroacupuncture; Fatigue; Female; Humans; Letrozole; Middle Aged; Nitriles; Quality of Life; Sleep Wake Disorders; Stress, Psychological; Treatment Outcome; Triazoles | 2014 |
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Severity of Illness Index; Sleep Wake Disorders; Triazoles | 2003 |
A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Topics: Adult; Affect; Ambulatory Care; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Placebos; Polysomnography; Psychiatric Status Rating Scales; Sleep; Sleep Wake Disorders; Treatment Outcome; Triazoles | 1997 |
Nefazodone for patients with chronic fatigue syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Fatigue Syndrome, Chronic; Female; Humans; Male; Middle Aged; Piperazines; Sleep Wake Disorders; Treatment Outcome; Triazoles | 1999 |
Trazodone in the treatment of psychoneuroses: a double-blind study.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Conversion Disorder; Female; Humans; Male; Middle Aged; Neurotic Disorders; Obsessive-Compulsive Disorder; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychomotor Disorders; Psychophysiologic Disorders; Pyridines; Sleep Wake Disorders; Time Factors; Triazoles | 1973 |
7 other study(ies) available for triazoles and Long Sleeper Syndrome
| Article | Year |
|---|---|
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
Topics: Animals; Azepines; Disease Models, Animal; Female; Hypnotics and Sedatives; Male; Mice; Mice, Transgenic; Sex Characteristics; Sleep; Sleep Wake Disorders; Tauopathies; Triazoles; Zolpidem | 2022 |
Chronotherapeutic efficacy of suvorexant on sleep quality and metabolic parameters in patients with type 2 diabetes and insomnia.
Topics: Aged; Azepines; Diabetes Mellitus, Type 2; Drug Chronotherapy; Female; Humans; Male; Prospective Studies; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Triazoles | 2020 |
Effects of an orexin receptor antagonist on blood pressure and metabolic parameters.
Topics: Adult; Aged; Animals; Azepines; Blood Pressure; Cholesterol, HDL; Female; Glucose; Humans; Hypertension; Male; Mice; Middle Aged; Models, Animal; Orexin Receptor Antagonists; Prospective Studies; Republic of Korea; Retrospective Studies; Sleep Wake Disorders; Triazoles | 2018 |
Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal.
Topics: Alcoholism; Animals; Azepines; Electroencephalography; Ethanol; Humans; Male; Orexin Receptor Antagonists; Rats; Rats, Wistar; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Sleep, REM; Sleep, Slow-Wave; Substance Withdrawal Syndrome; Time Factors; Triazoles | 2019 |
Safety and retention rate of rufinamide in 300 patients: a single pediatric epilepsy center experience.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Infant; Male; Patient Compliance; Prospective Studies; Retrospective Studies; Sleep Wake Disorders; Treatment Outcome; Triazoles; Vomiting; Young Adult | 2014 |
Induced next-day somnolence in an elderly patient taking suvorexant concomitantly with diltiazem.
Topics: Aged, 80 and over; Azepines; Diltiazem; Drug Interactions; Female; Humans; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Triazoles | 2016 |
Hypnotic and sleep quality-enhancing properties of kavain in sleep-disturbed rats.
Topics: Animals; Delta Rhythm; Diphenhydramine; Electroencephalography; Electromyography; Hypnotics and Sedatives; Male; Pyrones; Rats; Rats, Wistar; Sleep; Sleep Wake Disorders; Triazoles; Wakefulness | 2009 |